Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001013868 | SCV001174504 | pathogenic | Hereditary cancer-predisposing syndrome | 2019-07-17 | criteria provided, single submitter | clinical testing | The c.1968_1969delCTinsAC pathogenic mutation (also known as p.Y656*), located in coding exon 12 of the MSH2 gene, results from an in-frame deletion of CT and insertion of AC at nucleotide positions 1968 to 1969. This changes the amino acid from a tyrosine to a stop codon within coding exon 12. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |